基本情况

卢小玲，广西医科大学教授，博士生导师。

 

研究领域

肿瘤生物治疗方面、实验免疫学、细胞和分子免疫学、免疫学工程的研究

 

教育背景

2007年7月 博士，华中科技大学

2005年7月 硕士，华中科技大学

1999年7月 学士，咸宁医学院

 

论文发表

  1. Xiao-ling Lu, et al. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. Vaccine, 2008, 26: 5352–5357
  2. Xiao-ling Lu (Co-first author), et al. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma. Vaccine. 2009 Oct 19;27(44):6210-6
  3. Xiao-ling Lu, et al. Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response. [J] Cancer Letters, 2008, 271: 129-139
  4. Xiao-ling Lu, et al. In vivo anti-melanoma efficiency of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells. Cancer Immunol Immunother, 2009, 58: 629–638
  5. Xiao-ling Lu, et al. Generation of Allo-restricted Cytotoxic T Lymphocytes against Malignant Glioma by Artificial Antigen-presenting Cells. [J] Cancer Letters, 2007, 256: 128-135.  (SCI, IF=3.727)
  6. Xiao-ling Lu (Co-first author), et al. HLA Tetramer-based Artificial Antigen-presenting Cells Efficiently Stimulate Cytotoxic T Lymphocytes Specific for Malignant Glioma. [J] Clinical Cancer Research, 2007,13(24) 7329-7334
  7. Xiao-ling Lu (Co-first author), et al. Induction of Cytotoxic T Lymphocytes Specific to Malignant Glioma Using T2 Pulsed with HLA-A2-restricted Interleukin-13 Receptor α2 Peptide in vitro. [J] Acta Biochimica et Biophysica Sinica, 2007, 39 (9)
  8. XiaoLing LU, et al. Induction of the Epstein-Barr Virus Latent Membrane Protein 2 Antigen-specific Cytotoxic T Lymphocytes Using Human Leukocyte Antigen Tetramer-based Artificial Antigen-presenting Cells. [J] Acta Biochimica et Biophysica Sinica, 2006, 38(3): 157-163
  9. Xiao-Ling LU, et al. Construction and Functional Test of HLA-A*2402-peptide Tetramer. [J] Cellular ＆ molecular immunology, 2005,2(2):145-149
  10. Xiao-ling Lu (Co-first author), et al. Induction of Cytotoxic T-Lymphocytes Specific for Malignant Glioma by HLA Dimer-Based Artificial Antigen-Presenting Cells. [J] Cancer Biotherapy & Radiopharmaceuticals, 2007, 22 (6). (SCI, IF=1.763)
  11. Xiao-ling Lu (Co-first author), et al. Thermophysical properties of polycaprolactone/ chitosan blend membranes. Thermochimica Acta, 2009, 487: 33–38
  12. Xiao-ling Lu (Co-first author), et al. In vitro growth and activity of chondrocytes on three dimensional polycaprolactone/chitosan scaffolds. Polymers for Advanced Technologies. 2010